ARK Genomic Revolution ETF (BATS:ARKG) Hits New 52-Week High – What’s Next?

ARK Genomic Revolution ETF (BATS:ARKG)’s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $46.78 and last traded at $46.14, with a volume of 669417 shares trading hands. The stock had previously closed at $43.21.

ARK Genomic Revolution ETF Price Performance

The firm’s 50 day moving average price is $39.94 and its 200-day moving average price is $33.05.

Hedge Funds Weigh In On ARK Genomic Revolution ETF

Hedge funds and other institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its position in shares of ARK Genomic Revolution ETF by 30.6% during the 4th quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock valued at $149,180,000 after acquiring an additional 1,205,541 shares during the last quarter. Morgan Stanley grew its stake in shares of ARK Genomic Revolution ETF by 42.2% during the fourth quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock worth $116,632,000 after purchasing an additional 1,193,795 shares during the period. BNP Paribas Financial Markets increased its holdings in ARK Genomic Revolution ETF by 49.7% in the fourth quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock valued at $101,829,000 after purchasing an additional 1,167,558 shares during the last quarter. Wells Fargo & Company MN lifted its stake in ARK Genomic Revolution ETF by 29.1% in the fourth quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after buying an additional 290,301 shares during the period. Finally, LPL Financial LLC boosted its holdings in ARK Genomic Revolution ETF by 9.0% during the fourth quarter. LPL Financial LLC now owns 824,961 shares of the company’s stock worth $23,899,000 after buying an additional 68,267 shares during the last quarter.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.